RE: AstraZeneca buys immunology company Alexion for $39 Billion13 Dec 2020 08:58
It is quite puzzling to me to be honest. Although for example last year AZN generated over $24b in revenue, their profit was only $1.2b. This year ncyt will likely make about a quarter of the profit that Astra Zeneca does!
Perhaps big pharmas would rather see how novacyt position themselves in the diagnostics space over the next 6-12 months before attempting a buyout, even if it costs twice as much by then...